Valuation: Xiamen Kingdomway Group Company

Market Cap 9.83B 1.47B 1.34B 1.24B 1.12B 2.11B 138B 2.19B 14.9B 5.89B 74.32B 5.53B 5.41B 235B P/E 2026 *
23.7x
P/E 2027 * 16.5x
Enterprise Value 9.83B 1.47B 1.34B 1.24B 1.12B 2.11B 138B 2.19B 14.9B 5.89B 74.32B 5.53B 5.41B 235B EV / Sales 2026 *
2.62x
EV / Sales 2027 * 2.06x
Free-Float
39.49%
Yield 2026 *
2.67%
Yield 2027 * 4.12%
1 day-0.96%
1 week-4.13%
Current month-5.77%
1 month-1.32%
3 months+4.83%
6 months-0.12%
Current year-16.34%
1 week 16.22
Extreme 16.22
17.32
1 month 16.22
Extreme 16.22
19.19
Current year 12.9
Extreme 12.9
20.81
1 year 12.9
Extreme 12.9
20.81
3 years 10.71
Extreme 10.71
22.44
5 years 10.71
Extreme 10.71
33.91
10 years 10.71
Extreme 10.71
64.48
Manager TitleAgeSince
Chief Executive Officer 59 2010-04-17
Director of Finance/CFO 44 2016-04-11
Corporate Officer/Principal 62 2013-04-09
Director TitleAgeSince
Chairman 59 1997-10-31
Director/Board Member 62 2001-06-12
Director/Board Member 44 2019-04-11
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%-4.13%-19.64%-7.93% 1.47B
-1.58%+0.37%+8.59%-12.39% 266B
-1.17%+0.32%+20.12%-5.49% 84.49B
-1.16%+2.22%-10.76%+21.38% 49.49B
-0.66%-0.14%-2.96%-11.37% 34.91B
-1.63%+0.25%+18.27%-6.07% 33.06B
+1.23%+2.09%-5.21%-4.99% 30.98B
+0.65%+4.08%+13.44%+20.26% 30.74B
+0.16%+3.59%+2.53%-25.40% 29.73B
-0.80%-0.03%+1.55%+5.73% 26.73B
Average -0.59%+1.78%+2.59%-2.63% 59B
Weighted average by Cap. -1.04%+2.34%+7.30%-5.86%

Financials

2026 *2027 *
Net sales 3.76B 564M 512M 473M 426M 805M 52.66B 836M 5.7B 2.25B 28.42B 2.11B 2.07B 89.78B 4.76B 714M 648M 599M 540M 1.02B 66.72B 1.06B 7.22B 2.85B 36.01B 2.68B 2.62B 114B
Net income 424M 63.56M 57.7M 53.3M 48.08M 90.77M 5.94B 94.25M 642M 254M 3.2B 238M 233M 10.12B 609M 91.38M 82.96M 76.63M 69.14M 131M 8.54B 136M 923M 365M 4.61B 343M 336M 14.56B
Net Debt - -
Projected Income Statement - Annual - Xiamen Kingdomway Group Company
Logo Xiamen Kingdomway Group Company
Xiamen Kingdomway Group Co is a China-based company principally engaged in the research and development, production and sales of nutritional health foods (including raw materials and end products) and feed additives. The Company's raw materials include coenzyme Q10, Docosahexaenoic Acid (DHA), Arachidonic Acid (ARA), vitamin A, vitamin D3, vitamin K2, nattokinase, pyrroloquinoline quinone (PQQ), Nicotinamide Mononucleotide (NMN), astaxanthin, inositol series products and others. The feed additives produced by the Company include vitamin A, vitamin D3 and others. The Company also produces pharmaceutical raw materials such as praziquantel, alanylglutamine, and oxiracetam. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
2,184
Date Price Change Volume
26-11-17 CN¥16.49 -0.96% 4,163,061
26-11-16 CN¥16.65 -1.71% 7,949,693
26-11-13 CN¥16.94 +0.89% 8,293,297
26-11-12 CN¥16.79 -2.16% 6,693,600
26-11-11 CN¥17.16 -0.23% 5,925,108
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Xiamen Kingdomway Group Company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
16.49CNY
Average target price
23.02CNY
Spread / Average Target
+39.62%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Xiamen Kingdomway Group Company
  1. Stock Market
  2. Stocks
  3. 002626 Stock